Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants
about
Antibody persistence in mothers one year after pneumococcal immunization in pregnancyA longitudinal study of natural antibody development to pneumococcal surface protein A families 1 and 2 in Papua New Guinean Highland children: a cohort studyMouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies.Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae.Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trialNatural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study.Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort studyPneumococcal polysaccharide abrogates conjugate-induced germinal center reaction and depletes antibody secreting cell pool, causing hyporesponsiveness.Impact of intermittent preventive treatment in pregnancy with azithromycin-containing regimens on maternal nasopharyngeal carriage and antibiotic sensitivity of Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus: a cross-secActive Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisSynchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children.Rationale and prospects for novel pneumococcal vaccines.A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.Cord blood Streptococcus pneumoniae-specific cellular immune responses predict early pneumococcal carriage in high-risk infants in Papua New Guinea.Sustained reduction in vaccine-type invasive pneumococcal disease despite waning effects of a catch-up campaign in Kilifi, Kenya: A mathematical model based on pre-vaccination data.Viruses associated with influenza-like-illnesses in Papua New Guinea, 2010.Effect of maternally-derived anti-protein and anti-capsular IgG antibodies on the rate of acquisition of nasopharyngeal carriage of pneumococcus in newborns.Kinetics of antibodies against pneumococcal proteins and their relationship to nasopharyngeal carriage in the first two months of life.Intrapartum colonization with Streptococcus pneumoniae, early-onset sepsis and deficient specific neonatal immune responses.Comparison of neonatal T regulatory cell function in Papua New Guinean and Australian newborns.Rationale and methods of a randomized controlled trial of immunogenicity, safety and impact on carriage of pneumococcal conjugate and polysaccharide vaccines in infants in Papua New Guinea.Decreased performance of live attenuated, oral rotavirus vaccines in low-income settings: causes and contributing factors.Limited impact of neonatal or early infant schedules of 7-valent pneumococcal conjugate vaccination on nasopharyngeal carriage of in Papua New Guinean children: A randomized controlled trial
P2860
Q28392448-7DF54613-5EA2-46D8-BC41-CABB28CBA3C9Q33802029-7F6C6403-135D-4F61-92EB-B50D96A4EC12Q34134769-4BE9625F-06E6-4A57-80C1-976BD7D67DBCQ34193265-E81FAA95-FC61-450D-BC5E-FB762F0B82C3Q34595710-77F0BCB1-CB25-45D6-AD09-FBD304D137A7Q34602513-4A0D1380-C49A-4B7C-9D0F-36B357075ABDQ34740228-E68ED67A-BAC2-427E-854E-6DD2A0FE552CQ34803614-5CB172AE-05DA-447A-8E33-C13CF24D2EFAQ34998490-98117CDF-4001-48C9-9F05-F071C7F16DD1Q35193325-2CFBDC8A-4097-49C2-A44F-2EDF0A2AF200Q35826641-2773A7A8-B3F8-43F2-BCEC-B161C951B15EQ35887453-35C9F6C5-86EB-479B-9A8C-01D04FD2C933Q37309218-C4AFBA47-AE16-4DD2-8CAC-C380169C5676Q37333825-6E4D0C98-4A0F-4B9C-83B2-5ACBC7DEFC8FQ37619137-365135E2-AC4C-4860-8337-9C1F9C09E6B3Q37622565-2E775A90-51C8-4AA7-ABC1-A743CDC5F06CQ38669404-C3785D4B-6ED3-435F-8C7C-449797440B09Q40231098-D40C1FCB-DD62-4C01-AD98-8EAFAD95BCE5Q41987151-FED9785B-D216-40FA-AE10-CE2542BA185DQ41990743-65B10A42-ABF5-4AA0-975B-4022846995D3Q43658176-158956A6-3E49-4139-A24D-42924A762312Q46559927-243B5174-2ACD-47E1-A8CB-5DF4F85B8317Q47098110-2E7FB33E-91D5-4F45-ABE0-657C47487798Q47291480-92168A19-3B63-4484-ACB2-771B9465CF3CQ57272219-25A82985-8C35-4E75-AFE8-1BF300BD948F
P2860
Maternal antibodies to pneumolysin but not to pneumococcal surface protein A delay early pneumococcal carriage in high-risk Papua New Guinean infants
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Maternal antibodies to pneumol ...... risk Papua New Guinean infants
@en
Maternal antibodies to pneumol ...... isk Papua New Guinean infants.
@nl
type
label
Maternal antibodies to pneumol ...... risk Papua New Guinean infants
@en
Maternal antibodies to pneumol ...... isk Papua New Guinean infants.
@nl
prefLabel
Maternal antibodies to pneumol ...... risk Papua New Guinean infants
@en
Maternal antibodies to pneumol ...... isk Papua New Guinean infants.
@nl
P2093
P2860
P356
P1476
Maternal antibodies to pneumol ...... risk Papua New Guinean infants
@en
P2093
Anita H J van den Biggelaar
Audrey Michael
Deborah Lehmann
Helen Keno
Jacinta P Francis
Jan B Nelson
Melissa Whinnen
Patrick G Holt
Suparat Phuanukoonnon
Susan L Prescott
P2860
P304
P356
10.1128/CVI.00247-09
P577
2009-09-23T00:00:00Z